Related by context. All words. (Click for frequent words.) 71 XL# anticancer compounds 71 Inc. NASDAQ NOVC 70 Asentar ™ 70 candidate AQ4N 70 clinical trials dacetuzumab SGN 70 Xcytrin R 70 lintuzumab SGN 69 Submits Response 69 Telik logo TELINTRA 69 markets HP Acthar 69 developing ACAPODENE 69 XL# XL# XL# XL# 69 CORLUX CORT # 69 please visit http:/www.atherogenics.com 69 Completes Patient Enrollment 68 CD# CEA 68 4SC AG ISIN DE# 68 GVAX ® 68 IG HCR ;) CO 68 visit www.sciclone.com 68 developing ostarine selective 68 Initiates Enrollment 67 SinuNase ™ 67 CoTherix logo 67 Submits Biologics License Application 67 Luveris R Ovidrel R 67 Zemiva TM 67 Inc. www.micromet inc.com 67 Zemiva TM Trofex TM 67 BioSante licensees 67 Crofelemer budesonide foam 67 highly purified pasteurized 67 Kosan dependence 67 PRN FDA Approves 67 subsidiaries visit http:/www.apricusbio.com 67 Lexiscan ® 67 telomerase therapeutic 67 Initiates Phase II 67 Locteron exclusively 67 hypoxia activated prodrug 67 oncolytic virus therapies 67 pentadentate logo R 67 Therapeutic Competitors Companies 66 Exelixis logo 66 MCSP respectively 66 COLAZAL R 66 Hematide ™ 66 Genentech Wyeth Pharmaceuticals 66 Begins Dosing 66 candidate XP# 66 telomerase inhibitor drug 66 SinuNase TM 66 GVAX R 66 RAPTIVA R 66 R sorafenib tablets 66 sNDAs 66 Receive Milestone Payment 66 TRACON Pharmaceuticals 66 Submits NDA 66 novel MetAP 2 66 please visit http:/www.vandapharma.com 66 Taiho Pharmaceutical 66 R MSCRAMM 66 Announces Tentative Approval 66 clinical trials lintuzumab SGN 66 REMOXY POSIDUR ELADUR 66 Receives Milestone Payment 66 Phase IIa clinical trials 66 dacetuzumab SGN 66 TRANSDUR Sufentanil 66 KRYSTEXXA TM pegloticase 66 XP# XP# 66 Solazed TM 66 Allovectin 7 r 66 Maxy G# 66 PDX pralatrexate 65 Exherin 65 RAPTIVA r 65 Inc EXEL 65 commercializing Loramyc ® 65 BioSante Pharmaceuticals Announces 65 PANVAC VF 65 please visit www.medicinova.com 65 ENZON 65 TM Aganocide 65 AQ4N 65 markets Testim ® 65 Zemiva ™ 65 anti CD3 monoclonal 65 Naglazyme R 65 please visit www.middlebrookpharma.com 65 Receives Approvable Letter 65 commercialized DURECT 65 Pruvel ™ 65 Inc. Nasdaq OXGN 65 pradefovir 65 Nasdaq PGNX today 65 TELINTRA 65 dihydrochloride Phase 3 65 XL# XL# 65 compound KOS 65 novel emulsion formulation 65 DepoCyt ® Abelcet ® 65 Nasdaq HALO 65 MKC# MT 65 Milestone Payments 65 non nucleoside HCV 65 Pharma Merck Serono 65 candidate REP# 65 AcryMed Incorporated 65 clinical trials SGN 65 mocetinostat MGCD# 65 Initiates Phase III 65 Dyax logo 65 NASDAQ ENMD 65 Auxilium anticipates 64 Ecallantide 64 Phase Ib clinical trials 64 include Altastaph TM 64 Boehringer Ingelheim MedImmune 64 ALN PCS 64 P#X# antagonist 64 Albugon 64 oral nucleoside analogue 64 valtorcitabine 64 ESTRASORB R 64 HepeX B 64 dextromethorphan quinidine 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 Submits IND 64 Panzem R 64 Nasdaq SPPI 64 Nasdaq CYCC Nasdaq CYCCP 64 acetylgalactosamine 6 64 Retisert R 64 Azedra TM Onalta TM 64 Earns Milestone Payment 64 OctoPlus licensed 64 TRIOLEX HE# APOPTONE HE# 64 Nasdaq XTLB 64 commercialize becocalcidiol patented 64 Loramyc ™ 64 drug pipeline TAFA# 64 IV APAP 64 Inc. NASDAQ CEGE 64 StaphVAX R 64 TRANSDUR ™ 64 vapreotide acetate 64 CIMZIA r 64 please visit http:/www.sunesis.com 64 Aradigm Logo 64 Budesonide foam crofelemer 64 proprietary Capillary Aerosolization Technology 64 Entereg R 64 Initiates Clinical 64 molecular imaging radiopharmaceutical 64 Sensipar ® 64 AAG geldanamycin analog 64 initiated Phase Ib 64 JOULFERON 64 Presents Preclinical 64 methylnaltrexone bromide 64 Takeda Kyowa Hakko Kirin 64 include ClindaReach TM 64 Ostarine ™ 64 Trofex ™ 64 Amigal TM 64 Through Glycoscience R 64 CEFF financings subject 64 technology visit http:/www.genmab.com 64 Cardium Therapeutics TM 64 Xoma Ltd 64 OTC BB PVCT 64 Empatic ™ 64 Nanobody R 64 Nasdaq PDLI 64 Vitamin D analogue 64 Omigard TM 64 Inc. NASDAQ ZLCS 64 NASDAQ LGND 64 lead molecular radiotherapeutic 64 HepeX B TM 63 Completes Enrollment 63 successfully commercialize Iluvien 63 virus HCV protease inhibitor 63 Merck OSI Pharmaceuticals 63 Files IND 63 palonosetron hydrochloride injection 63 evaluating intravenous picoplatin 63 www.telik.com 63 Veronate R 63 International LAB Pharma 63 TELINTRA R 63 cinacalcet HCl 63 Receives Orphan Drug 63 Licenses Novel 63 DARA logo 63 proprietary radiolabeled monoclonal 63 TRAIL receptor antibodies 63 Nasdaq PARD 63 Somatuline Depot 63 visit www.noven.com 63 Presents Preclinical Data 63 Ovitrelle R Serostim 63 TRANSDUR ® 63 initiated Phase 1b 63 candidate MyVax 63 Nabi HB R 63 Roche OTC RHHBY 63 Kuvan TM sapropterin 63 Increlex TM 63 dacetuzumab collaboration 63 Merck Serono Nycomed 63 tivozanib AV 63 visit www.targanta.com 63 Achieves Primary Endpoint 63 Rotarix ® 63 investigational monoclonal antibody 63 Nasdaq ENMD 63 Files Investigational 63 Staphylococcus aureus Immune Globulin 63 Receives Orphan Drug Designation 63 FACTIVE R gemifloxacin 63 POSIDUR TM ELADUR TM 63 Personalized Immunotherapy 63 NYSE Amex PTN 63 candidates Azedra TM 63 CancerVax Corporation 63 PLK1 SNALP 63 FOLOTYN ® 63 NasdaqGM SPPI 63 motexafin gadolinium Injection 63 ELADUR TM 63 Pharmion Corporation 63 acetonide FA 63 includes TOLAMBA TM 63 ARCALYST R 63 www.adeonapharma.com 63 website www.celsion.com 63 EVIZON TM squalamine lactate 63 tramiprosate Alzhemed TM 63 Panzem R NCD 63 NOVC 63 MAb therapy 63 website http:/www.sinovac.com 63 5 lipoxygenase inhibitor 63 RECOTHROM ® 63 Nicotine Conjugate Vaccine 63 Reports Preclinical Data 63 MSCRAMM ® 63 Nasdaq CLDX 63 Nasdaq DVAX 63 CysDisplay R 63 Besivance 63 Inc. NASDAQ ONTY 63 Presents Positive 63 Enzon Pharmaceuticals Inc 63 Regeneron Pharma 63 product candidate Lpathomab 63 PF # [002] 63 adecatumumab MT# 63 Acetavance TM 63 commercialize CorMedix drug 63 DPX Survivac 63 ThermoDox ® clinical 63 molecular chaperone regulation 63 include GALNS N 63 GlaxoSmithKline MedImmune 63 Fludara ® 63 Announces Poster Presentations 63 vii Cubist ability 63 eprodisate KIACTA TM 63 visit www.genmab.com 63 arsenic trioxide injection 63 Trubion proprietary 63 www.cellgenesys.com 63 ViroChem Pharma Inc. 63 inflammatory autoimmune diseases 63 TKB# 63 Syntonix Pharmaceuticals 63 midstage trials 63 Lexiscan R 63 Trastuzumab DM1 63 TriPath Oncology 63 topical anti infective 63 Initiates Clinical Trial 63 RTP #i 63 Tyzeka Sebivo 63 Milestone Payment 63 diabetes irritable bowel 63 OMNARIS Nasal Spray 63 visit www.novabaypharma.com 62 MAXY alpha 62 novel therapeutic antibodies 62 Shigamabs ® 62 Inc Therapeutic Competitors 62 Altus Pharmaceuticals 62 SPRYCEL ® 62 HuMax TAC 62 XL# XL# XL# 62 Dynepo TM 62 Nasdaq AVNR 62 BioGlue ® 62 Nasdaq ABII 62 By JAMAAL ABDUL 62 Nasdaq LGND 62 Allos retains exclusive 62 rThrombin 62 Germany FSE SCH 62 Cephalon GlaxoSmithKline 62 Cytogen marketed 62 rheumatoid arthritis thrombocytopenia 62 elotuzumab 62 AzaSite Plus 62 novel orally inhaled 62 please visit www.advaxis.com 62 Valortim TM 62 Receives Fast Track 62 Pruvel 62 Agonist MABA program 62 trastuzumab Herceptin R 62 staphylococcal vaccines 62 MOVIPREP R 62 SpeBio joint venture 62 sapropterin dihydrochloride 62 Alnylam Nasdaq ALNY 62 NV Organon 62 ocular formulation 62 SAR# [004] 62 Potelligent Technology 62 NASDAQ PGNX 62 Inc. Nasdaq MITI 62 Inc CRIS 62 Fibrosis Foundation Therapeutics 62 Nasdaq OSIP 62 LUCENTIS r 62 formerly Sorrent 62 www.micromet inc.com 62 Hematide ™ peginesatide 62 Submits Supplemental 62 Pruvel ™ prulifloxacin 62 JAK2 Inhibitor 62 UltiMAb 62 Nasdaq MBRX 62 TRISENOX R 62 Announce License Agreement 62 novel L DOS# 62 pralatrexate injection folate analogue 62 squalamine 62 mertansine 62 MT#/MEDI-# 62 Genentech sanofi aventis 62 AzaSite TM 62 TransVax TM 62 Evoltra ® 62 nalbuphine ER 62 Vitaxin 62 Rexahn licensees 62 ZEGERID Capsules 62 ® bortezomib 62 BTG plc 62 zileuton tablets 62 developing adecatumumab 62 topical antifungal product 62 Other ImmunoGen collaborative 62 Presents Positive Preclinical 62 based pretargeting methods 62 label Lipofen R 62 OTC BB PVCT http:/www.pvct.com 62 albiglutide 62 biomimetics non 62 Inc. NASDAQ SGEN 62 Neulasta R 62 BRILINTA 62 RELOVAIR ™ 62 agonistic human 62 Barr ANDA 62 Asentar 62 R lenalidomide 62 lumiliximab 62 product platforms AZX# 62 TRISENOX ® 62 ELADUR ™ 62 Thalomid ® 62 FUSILEV ® 62 PREOS R 62 Micromet proprietary BiTE 62 generation DACH Platinum 62 Dacetuzumab 62 Taisho Pharmaceuticals 62 MSCRAMM R 62 Augment TM 62 Ophthotech 62 Selective Electrochemical Tumor Ablation 62 gastrointestinal disorders ATI 62 Files Shelf Registration Statement 62 BioGlue R 62 Solazed 62 novel synthetic PEGylated 62 proprietary intravenous formulation 62 drugs FUSILEV 62 small molecule glucokinase 62 R rilonacept Injection 62 Inc. Nasdaq CRTX 62 nasal calcitonin product 62 please visit www.lexpharma.com 62 interferon gamma 1b 62 Oracea TM 62 evaluating satraplatin 62 huC# DM4 62 Inc. Nasdaq IMGN 62 intravenous acetaminophen 62 Predictive medicine 62 Troxatyl 62 Miikana 62 ZFNs clinical trials 62 Inc. NASDAQ TRMS 62 class anticancer quinolone 62 Onco TCS 62 Urocidin TM 62 ZALBIN ™ 62 Genitope Corporation 62 diagnostic radiopharmaceutical 62 brand ciclesonide HFA 61 HEPLISAV TM 61 IgG1 monoclonal antibody 61 including eniluracil ADH 61 collaborator Bayer HealthCare 61 Advancing Drugs 61 triciribine phosphate monohydrate 61 VISICOL R 61 Vitrasert R 61 Mircette R 61 BiovaxID TM 61 BUPHENYL R 61 targeted radiotherapeutic 61 Thalomid R 61 Proquin XR 61 orBec ® oral beclomethasone 61 Aurexis R 61 ularitide 61 Femring ® 61 vaccine GRNVAC1 61 TRANSDUR Bupivacaine 61 JAK inhibitor 61 PGL# 61 CYT# vascular disrupting 61 Aurora kinase inhibitor 61 secretory phospholipase A2 61 Nasdaq VNDA 61 AcryMed technologies 61 HYVISC R 61 Nycomed GmbH 61 evaluating picoplatin 61 Argatroban 61 Campto 61 candidates Augment ™ 61 mitogen activated ERK kinase 61 rusalatide acetate 61 products MKC# PP 61 Rhucin ® recombinant 61 Captisol ® 61 Cerexa Inc. 61 MAGE A3 ASCI 61 Nasdaq NPSP announced 61 valopicitabine NM# 61 SYCREST 61 website http:/www.depomed.com 61 oral prodrug 61 NASDAQ OSIP announced 61 2 methoxyestradiol 61 INDICATED LOWER 61 http:/www.pharmion.com 61 Transcept Pharmaceuticals 61 candidate Hematide TM 61 recombinant biopharmaceutical 61 LymphoStat B TM 61 Colaris Colaris AP 61 Teveten 61 TRIOLEX ™ 61 InterfeRx 61 NUEDEXTA ™ 61 Pivotal Phase III 61 ONSOLIS TM 61 NDA Submission 61 TOCOSOL Camptothecin 61 targeting Inflammatory Bowel 61 Intravenous Human 61 sanofi aventis Bayer Schering 61 docetaxel Taxotere R 61 Solzira TM 61 Tech DVAX 61 Sulonex TM 61 rilonacept Injection 61 Anturol ® 61 lexidronam injection 61 Pirespa 61 candidate deforolimus 61 Inc. Nasdaq TRMS 61 visit www.solitaireminerals.com 61 HEPLISAV ™ 61 Nasdaq IDIX 61 Zorbtive TM 61 RapMAT R 61 Iluvien ® 61 Gentamicin Surgical Implant 61 danoprevir 61 sumatriptan succinate 61 progressive metastatic prostate 61 GATTEX TM 61 Inc. Nasdaq VVUS 61 non nucleoside inhibitor 61 Corp. PHRM 61 DRRX 61 NASDAQ SCMP 61 Ortho Cept 61 sterile lidocaine patch 61 HCV RNA polymerase 61 orally administered inhibitor 61 Aloxi ® 61 candidate SILENOR TM 61 Nasdaq NBIX 61 catheter occlusion 61 Generx TM 61 Pharmos pipeline 61 Commercialization Agreement 61 vernakalant oral 61 Nasdaq EPCT 61 apricitabine ATC 61 CD4 monoclonal antibody 61 Dacogen injection 61 Phase 2b Clinical Trial 61 NasdaqGM NTEC today 61 oxymorphone ER 61 peramivir BCX 61 Testosterone MDTS ® 61 website http:/www.celsion.com 61 androgen receptor modulator 61 HuCAL GOLD R 61 CDP# 61 investigational humanized monoclonal antibody 61 Inc. NASDAQ QLTI 61 ALN HPN 61 dihydrochloride Tablets 61 Adentri 61 Soliris TM eculizumab 61 Onalta ™ 61 Exelixis compounds 61 evaluating bafetinib 61 TKPHF 61 severe hypercholesterolemia 61 Oral Calcitonin 61 Allovectin 7 61 vosaroxin 61 TOCOSOL Paclitaxel 61 sanofi aventis GlaxoSmithKline 61 NeutroPhase TM 61 www.oncogenex.com 61 sapacitabine CYC# 61 Pegloticase 61 LSE SHP.L 61 subsidiary Embryome Sciences 61 Enrolls First 61 Amgen Bayer Schering 61 SPL# Gel vaginal microbicide 61 ® decitabine 61 http:/www.marinabio.com 61 psoriasis rheumatoid arthritis 61 omecamtiv mecarbil formerly 61 Namenda Memantine HCl 61 Inc. Nasdaq ABGX 61 Harbor BioSciences 61 ASE SVA 61 cosmetic cosmeceutical products 61 thrombin component 61 Zenvia ™ 61 proprietary intranasal insulin 61 Tibotec BVBA 61 Nasdaq PGNX 61 Orapred ODT 61 ALLEGRA ® 61 pharmacogenomic translational research 61 phase III isavuconazole 61 Phase III Pivotal 61 TP# CETi 1 61 alvespimycin 61 GTC NASDAQ GTCB 61 TNFerade ™ 61 Levoleucovorin 61 Meets Primary Endpoint 61 SAR# [002] 61 AzaSite Xtra 61 please visit http:/www.supergen.com 60 Xeloda ® 60 NASDAQ ACOR 60 http:/www.unigene.com 60 Aganocide 60 delivers fluocinolone acetonide FA 60 refractory chronic lymphocytic 60 Initiates Phase 60 Reveals Positive 60 NSE SUNPHARMA 60 palonosetron hydrochloride Injection Dacogen 60 visit www.genenews.com 60 NASDAQ OGXI 60 Inc AMGN AMGN 60 testosterone buccal system 60 metabolic disorders Saizen R 60 include PLX IBD 60 LOMUCIN TM 60 Dementia Related Psychosis 60 Inc. Nasdaq ONTY 60 Actimmune R 60 Fortical ® 60 proprietary BiTE ® 60 Biological License Application 60 memantine HCl 60 novel VDA molecule 60 ionotropic glutamate receptor antagonists 60 LEP ETU 60 NASDAQ BDSI 60 corticotropin injection 60 neuropathic pain metabolic diseases 60 Modrenal R 60 NRGN 60 R Saizen R 60 Initiates Dosing 60 dasatinib Sprycel ® 60 developing Zerenex ferric 60 Sensipar R 60 using VIAdel TM 60 severe hypersensitivity reactions 60 Tiuxetan 60 Bifunctional Muscarinic Antagonist Beta2 60 PEG SN# 60 please visit www.sucampo.com 60 Nasdaq CADX 60 Idenix Pharmaceuticals Inc 60 Symphony tCGM 60 LEUKINE 60 ZADAXIN ® 60 AstraZeneca AZN.L 行情 60 oral calcitonin 60 addressing idiopathic pulmonary 60 molecular therapeutics immunotherapies 60 QUADRAMET R 60 markets COLAZAL 60 Vidaza R 60 http:/www.nastech.com 60 Protexia ® 60 NASDAQ KERX 60 FavId 60 Zeneus 60 HuCAL PLATINUM R 60 Nasdaq IPXL 60 PEG PAL PEGylated recombinant 60 Belinostat 60 outlicensed 60 candidate ridaforolimus 60 diarrhea fatigue asthenia 60 Boehringer Ingelheim CHDI Novartis 60 Tibotec Therapeutics division 60 Nasdaq GTCB 60 PROSTASCINT R 60 SHP.L 60 Initiate Phase 60 Auxilium Pharma 60 dependent kinase inhibitor 60 HIV integrase inhibitor 60 Zovirax R 60 Phase IIb Trial 60 PentaStaph 60 registrational studies 60 NASDAQ MNKD focuses 60 PORxin TM platforms 60 Unit Dose Budesonide 60 Phase III LibiGel 60 IMPDH inhibitor 60 Cleviprex TM clevidipine 60 polysaccharide polymer 60 developing Zerenex TM 60 LymphoStat B belimumab 60 Phase lll 60 Eligard ® 60 AstraZeneca PLC Arimidex 60 TSX VENTURE GAP 60 treat refractory angina 60 NASDAQ PHRM 60 Nasdaq SLXP 60 Stimuvax R 60 Bullish Technical Alert 60 researches develops licenses 60 candidate NGX 60 Idec Roche Takeda 60 GTC recombinant human 60 Syncria 60 IV Busulfex 60 forodesine hydrochloride 60 Inc. Nasdaq NEOL 60 IMiD 60 Fast Track designations 60 Rosetta dependence 60 Corp EPCT 60 Nasdaq VRTX 60 PNP inhibitor 60 developing chemokine 60 NASDAQ REGN 60 OMAPRO ™ 60 Launches Generic Version 60 budesonide foam 60 Mylan Receives Approval 60 supplemental biologics 60 ZALBIN 60 visit www.sanofi aventis.us 60 Pruvel TM 60 Soriatane 60 Xyntha 60 alpha interferons 60 AIMM trial 60 acyclovir Lauriad R 60 Spectrum Pharmaceuticals Announces 60 Inc. NASDAQ EVVV 60 novel histone deacetylase 60 tiapamil 60 OTCBB ARDM 60 Gets FDA Clearance 60 INSPIRE Trial Phase III 60 NASDAQ ENZN 60 TM pralatrexate injection 60 AlgoRx 60 ELADUR 60 personalized dendritic cell 60 OTCBB HXBM developer 60 CIP ISOTRETINOIN 60 Somatuline Autogel 60 glucokinase activator 60 MacroChem Corporation 60 IMiDs 60 Prestara 60 Oral Suspension USP 60 vinorelbine emulsion 60 Ceflatonin R 60 Oracea ® 60 Tarsa Therapeutics 60 midstage clinical 60 mesylate tablets approved 60 PROMACTA ® 60 CombinatoRx Incorporated 60 DIFICID ™ 60 Copegus R 60 Atrisorb D R 60 commercialize ZYFLO CR 60 CEL SCI Phase III 60 Solazed ™ 60 confirmatory Phase III 60 Inc. ProMetic www.prometic.com 60 NeoMagic circle 60 prostone 60 CholeraGarde R Peru 60 Somatuline R Depot 60 www.cerus.com 60 NASDAQ CRXL 60 Peggy Pinkston 60 Xibrom TM 60 SILENOR 60 website www.depomed.com 60 AERx iDMS 60 miconazole Lauriad R 60 Thrombin topical Recombinant 60 Nasdaq DYAX 60 Aganocide ® 60 Trofex TM 60 Aganocide TM 60 Nasdaq NPSP 60 Orphan Drug designations 60 Nasdaq RXII 60 Dexilant 60 please visit www.eisai.com 60 Palatin Technologies Inc. 60 Onalta 60 Granted Orphan Drug 60 Frova ® 60 ospemifene 60 STRIANT ® 60 gastro intestinal inflammation 60 Phase #b/#a clinical 60 Azedra ™ 60 OTCBB URGP specialty 60 Cadila Pharmaceuticals named 60 company website www.novavax.com 60 Nasdaq MITI 60 Roche SWX ROG 60 ASX PGL 60 Celgene Thalomid 60 NASDAQ ABII 60 Vascular Wrap TM 60 Premarket Approval Application 60 InvaGen 60 AzaSite ISV 60 Azmacort R 60 delivery polymer matrix 60 Retisert ® 60 REBETOL combination therapy 60 JZP 60 sodium thiosulfate STS 60 Nuvelo Announces 60 candidate CRLX# 60 CIP TRAMADOL ER 60 NASDAQ BMRN 60 Omigard 59 PSDV 59 Peyronie disease Frozen Shoulder 59 Excellarate TM 59 AZX# 59 PHRM 59 #D#C# 59 phase IIb clinical 59 R bendamustine hydrochloride 59 cMET inhibitor 59 Myriad logo BRACAnalysis 59 XIAFLEX ® 59 Clinical Trials Agreement 59 PLAVIX ® 59 commercialize SGN 59 Kosan motilin agonist 59 Metabasis stockholders 59 sumatriptan injection 59 http:/www.gpc-biotech.com 59 BUPHENYL 59 Pivotal Phase 59 Calixa 59 cetuximab Erbitux R 59 interferon alfacon 1 59 Methylphenidate Transdermal System 59 apoptosis inducer 59 Campath ® 59 HCl Tablets 59 Therapeutic Competitors 59 #/#/# Cytokinetics Incorporated 59 OTCBB QTXB 59 OvaRex ® MAb 59 S1P antibody 59 ruxolitinib 59 Company website www.anormed.com 59 AKIP ™ 59 Indevus Pharma 59 Eloxatin ® 59 oxandrolone USP 59 visit http:/www.mannkindcorp.com 59 sapropterin dihydrochloride Tablets 59 2 inhibitor CYT# 59 website www.novavax.com 59 Inc. NASDAQ ACOR 59 Glufosfamide 59 rash pruritus nausea 59 Inc. Nasdaq SGXP 59 PEGylated docetaxel 59 oral picoplatin 59 miconazole MBT 59 GATTEX ® 59 Eligard R 59 RANK Ligand inhibitor 59 sumatriptan succinate injection 59 Nasdaq AEGR 59 Nasdaq IMGN 59 Nasdaq SGEN 59 documented candidiasis 59 Axcan Pharma Holding BV 59 Please visit www.antisoma.com 59 Fortigel 59 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 59 Nabi HB Intravenous 59 Ostarine TM 59 sodium glucose transporter 59 Sunesis Pharmaceuticals 59 ViroChem 59 Xolegel Vusion 59 Canvaxin TM 59 BiTE R 59 evaluating tivozanib 59 THALOMID 59 prokinetic agent 59 Corporation GENZ 59 Kuvan R 59 phenylalanine ammonia lyase 59 selectin antagonist 59 INFeD R 59 Pharmacopeia Phase 59 MBRX 59 Daclizumab 59 Tramiprosate ALZHEMED TM 59 docetaxel Taxotere ® 59 Investigational Oral 59 Hybridon 59 rasagiline tablets 59 GlaxoSmithKline Amgen 59 ZYFLO R 59 HCD# [002] 59 Hematide TM 59 Oxytrol R 59 adenosine injection 59 NPS NPS Pharmaceuticals 59 Demonstrates Significant 59 equine osteoarthritis marketed 59 Nasdaq IMMU 59 Quark Biotech 59 IL# PE#QQR 59 hyaluronidase enzyme 59 INxin TM 59 systemic Phase 1b 59 investigational pharmacologically unique 59 Rinat Neuroscience 59 Successfully Completes Phase 59 EPIX Pharmaceuticals 59 Regains NASDAQ 59 NASDAQ OPTR 59 CORT # estimates 59 HGS ETR1 mapatumumab 59 Cephalon GlaxoSmithKline Organon 59 Nasdaq PPHM 59 novel proprietary KL4 59 Civacir 59 REGN# 59 PDE4 inhibitor 59 Nektar proprietary 59 anti botulism antibody 59 Submits Investigational 59 ESTRASORB ® 59 Calixa Therapeutics 59 valopicitabine 59 Nasdaq AUXL 59 NASDAQ AKRX 59 NEBIDO R 59 Oxis International 59 AN# topical anti 59 MGCD# MGCD# [001] 59 Beyond Advair 59 research anddevelopment 59 Allovectin 7 R 59 Proprius Pharmaceuticals 59 Nasdaq CTIC 59 Agenerase 59 ARIKACE ™ 59 oral proteasome inhibitor 59 Vertex retains 59 DEB# 59 CYCLOSET ® 59 Vegenics 59 telaprevir VX 59 TRAIL receptor antibody 59 AMEX TTP 59 R vancomycin hydrochloride 59 RhuDex TM 59 RELISTOR ® 59 NASDAQ DRRX 59 targets Galectin receptors 59 programs visit http:/www.bionovo.com 59 Synerx 59 CYT# potent vascular disrupting 59 Janssen AI 59 IV FENTORA R 59 EntreMed Inc. 59 Dynepo 59 Actimmune ® 59 Akorn Strides 59 Gonal f R 59 HCV polymerase inhibitors 59 next generation URAT1 59 Aradigm Announces 59 Kyowa Kirin 59 Lamictal ODT 59 NASDAQ MOGN 59 Aflibercept 59 please visit www.dsi.com 59 gets USFDA nod 59 Receives NASDAQ 59 Busulfex 59 Nexavar prescribing 59 Biogen Genentech 59 Amends Agreement 59 oral dihydropyrimidine dehydrogenase DPD 59 MKC# 59 Initiates Phase 2b 59 subsidiaries InnerCool Therapies 59 CTA# Injection 59 fludarabine phosphate 59 liver resection surgeries 59 RECOTHROM R 59 personalized cellular immunotherapy 59 Inc. Nasdaq SGEN 59 HCV polymerase 59 Raptiva R 59 INTEGRILIN R eptifibatide Injection 59 XOMA 3AB 59 RAPTIVA 59 markets Gelclair R 59 JV SpeBio 59 Phase IIb clinical trials 59 Tezampanel